Skip to main content

Table 2 Baseline characteristics of the placebo (n = 31) and DRB (n = 30) groups

From: Effect of defatted rice bran supplementation on metabolic parameters and inflammatory status in overweight/obese adults with hypercholesterolemia: a randomized, placebo-controlled intervention

Parameters

Placebo (n = 31)

DRB (n = 30)

Anthropometrics parameters

Age (years)

31.71 ± 12.27

36.87 ± 12.30

Sex

    Female

23 (74.2%)

21 (70.0%)

    Male

8 (25.8%)

9 (30.0%)

Height (cm)

163.48 ± 9.16

162.08 ± 8.26

Body weight (kg)

75.38 ± 15.56

77.76 ± 16.75

BMI (kg/m2)

28.10 ± 4.50

29.45 ± 4.57

Waist circumference (cm)

93.60 ± 11.03

95.09 ± 10.86

Fat mass (kg)

27.68 ± 10.26

30.21 ± 10.20

Fat-free mass (kg)

47.74 ± 10.82

47.48 ± 10.43

Muscle mass (kg)

45.02 ± 10.38

44.52 ± 10.48

Relative fat mass

37.60 ± 6.63

38.30 ± 5.58

Visceral adiposity index

2.07 ± 1.00

1.64 ± 0.96

SBP (mmHg)

122.13 ± 15.05

126.20 ± 13.63

DBP (mmHg)

78.45 ± 10.32

80.87 ± 7.38

Blood biochemical parameters

  FBG (mg/dL)

99.13 ± 27.95

94.93 ± 22.79

  HbA1c (%)

5.89 ± 0.67

5.89 ± 0.76

  Serum Insulin (uIU/mL)

9.16 ± 4.28

8.50 ± 4.37

  HOMA-IR

2.10 ± 1.04

2.14 ± 1.50

  QUICKI

0.35 ± 0.03

0.35 ± 0.03

  TC (mg/dL)

236.32 ± 30.44

242.00 ± 46.45

  TG (mg/dL)

131.27 ± 58.99

121.52 ± 64.94

  LDL-c (mg/dL)

158.94 ± 33.57

165.40 ± 37.69

  HDL-c (mg/dL)

51.35 ± 10.21

57.7 ± 13.21*

  LDL:HDL ratio

3.19 ± 0.80

3.06 ± 0.87

  hs-CRP (mg/L)

2.74 ± 1.91

1.88 ± 1.59

  Homocysteine (μmol/L)

10.69 ± 3.07

11.37 ± 3.29

Dietary intake

  Energy (kcal/day)

1,689.29 ± 428.64

1,770.4 ± 257.16

  Carbohydrate (g/day)

212.29 ± 57.58

225.37 ± 45.77

  Protein (g/day)

74.09 ± 31.16

71.94 ± 15.24

  Fat (g/day)

60.81 ± 20.72

64.80 ± 16.39

Energy distribution

  Carbohydrate (%)

51.35 ± 7.03

51.35 ± 7.53

  Protein (%)

17.10 ± 4.58

16.37 ± 2.86

  Fat (%)

31.55 ± 6.04

32.28 ± 6.37

Gastrointestinal symptoms parameters

  Flatulence

0.4 ± 0.82

0.41 ± 0.68

  Borborygmi

0.63 ± 0.72

0.59 ± 0.82

  Nausea

0.07 ± 0.25

0.10 ± 0.56

  Vomiting

0.00 ± 0.00

0.07 ± 0.37

  Stomach pain

0.27 ± 0.69

0.17 ± 0.47

  Passing flatus

0.73 ± 0.91

0.66 ± 0.81

  Bristol stool form

4.37 ± 1.38

4.17 ± 1.23

  1. All values are expressed as the mean ± SD. Significant differences between categorical variables of the two study groups were determined by the chi-square test. Significant differences between continuous variables of the two study groups were determined by independent t-tests. *P-value ≤ 0.05 is considered to indicate a statistically significant result
  2. SBP Systolic blood pressure, DBP Diastolic blood pressure, BMI Body mass index, FBG Fasting blood glucose, HOMA-IR The homeostatic model assessment of insulin resistance, QUICKI The quantitative insulin sensitivity check index, TC Total cholesterol, TG Triglycerides, LDL-c Low-density lipoprotein, HDL-c High-density lipoprotein